0001494650-21-000145.txt : 20211213
0001494650-21-000145.hdr.sgml : 20211213
20211213155547
ACCESSION NUMBER: 0001494650-21-000145
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211210
FILED AS OF DATE: 20211213
DATE AS OF CHANGE: 20211213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dempsey Kyle
CENTRAL INDEX KEY: 0001897585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38241
FILM NUMBER: 211488022
MAIL ADDRESS:
STREET 1: OLD CITY HALL
STREET 2: 45 SCHOOL STREET
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OptiNose, Inc.
CENTRAL INDEX KEY: 0001494650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421771610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 STONY HILL ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
BUSINESS PHONE: 267-364-3500
MAIL ADDRESS:
STREET 1: 1020 STONY HILL ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
4
1
wf-form4_163942893483015.xml
FORM 4
X0306
4
2021-12-10
0
0001494650
OptiNose, Inc.
OPTN
0001897585
Dempsey Kyle
C/O OPTINOSE, INC.
SUITE 300
YARDLEY
PA
19067
1
0
0
0
Stock Option (Right to Buy)
1.63
2021-12-10
4
A
0
28879
0
A
2031-12-10
Common Stock
28879.0
28879
D
The option vests and becomes exercisable over a three-year period commencing on December 10, 2021. Thirty-three percent (33%) of the option vests and becomes exercisable on December 10, 2022, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer.
/s/ Anthony Krick, Attorney-in-Fact
2021-12-13